BSX: Post-market Study Data Reinforce Success & Safety Of AC

WASHINGTON (dpa-AFX) - Boston Scientific Corp. (BSX) said that post-market study data reinforced clinical procedural success and safety of the ACURATE neo2 Aortic Valve System.The ACURATE neo2

Related Keywords

Boston , Massachusetts , United States , Canada , Washington , Kostenloser Wertpapierhandel , Boston Scientific Corp , , Market Clinical Follow Up , Valve System , Post , Market , Study , Data , Reinforce , Success , Safety , Accurate , Heo2 , Aortic , Valve , System ,